Despite incontrovertible evidence of the harmful effects of endocrine disruptors, a sound public health policy is still absent. Meanwhile, the press has revealed the hindering role of industry lobbyists and conflicts of interest among members of the regulatory bodies. Here, we identify another hindrance; one that stems from current experimental research practices.